BiotechTube
Home/Zylo Therapeutics/Andrew Draganski, PhD
AD

Andrew Draganski, PhD

Vice President, Product Development

Zylo Therapeutics

Therapeutic Areas

DermatologySkincare/Cosmeceuticals

Zylo Therapeutics Pipeline

DrugIndicationPhase
AEA for Lupus (w/ Atticus Pharma)Lupus skin lesionsPre-clinical
Follicular Targeting ProgramAcne, AlopeciaResearch/Discovery
Solubility Enhancement ProgramUndisclosedResearch/Discovery
Y100 Mitochondrial BiogenesisSkin rejuvenation/restorationResearch/Discovery

Leadership Team at Zylo Therapeutics

SR
Scott R. Pancoast
CEO & Founder
CE
Charles E Hinkle
Chief Financial Officer
CT
Clay Tucker
Research Scientist
MZ
Michael Z Rabin
Special Advisor, Strategy
View full Zylo Therapeutics profile